Table 1 Diagnostic performance of proposed biosensor for detection of SARS-CoV-2 by samples and study groups in FVL case.
Proposed Immunosensor | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
RT-PCR* | NA | OS | SA | At least one positive sample per participantd | All samples | ||||||
+ | − | + | − | + | − | + | − | + | − | ||
Patientsa | + | 4 | 1 | 13 | 1 | 6 | 3 | 15 | 2 | 23 | 5 |
− | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Co-habitantsb | + | 0 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 4 | 2 |
− | 0 | 2 | 3 | 3 | 3 | 2 | 4 | 3 | 6 | 7 | |
Healthy donorsc | + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
− | 2 | 2 | 2 | 5 | 2 | 4 | 5 | 4 | 6 | 11 | |
All | + | 4 | 3 | 15 | 1 | 8 | 3 | 17 | 2 | 27 | 7 |
− | 2 | 4 | 5 | 8 | 5 | 6 | 9 | 7 | 12 | 18 | |
PPV % (95% CI) | 66.7 (22.3–95.7) | 75 (50.9–91.3) | 61.5 (31.6–86.1) | 65.4 (44.3–82.8) | 69.2 (52.4–83) | ||||||
NPV % (95% CI) | 57.1 (18.4–90.1) | 88.9 (51.8–99.7) | 66.7 (29.9–92.5) | 77.8 (39.9–97.2) | 72 (50.6–87.9) | ||||||
Likelihood ratio (+) | 1.71 (0.47–6.30) | 2.44 (1.21–4.90) | 1.60 (0.76–3.36) | 1.59 (1.01–2.52) | 1.99 (1.24–3.18) | ||||||
Likelihood ratio (−) | 0.64 (0.23–1.79) | 0.10 (0.01–0.71) | 0.50 (0.17–1.51) | 0.24 (0.06–1.00) | 0.34 (0.17–0.71) |